subscribeSubscribe
FDA rebukes small biotech Althera for promotional claims

FDA rebukes small biotech Althera for promotional claims
Ben Adams FIERCEPHARMA
13 Jun 2022
Share Share
Pharma patent appeals dismissed by Court of Appeal

Pharma patent appeals dismissed by Court of Appeal
IRISHTIMES
28 Jan 2022
Share Share
Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Novartis wins FDA approval for new heart drug, but faces uphill sales battle
J. Gardner BIOPHARMADIVE
23 Dec 2021
Share Share
Amgen seeks SCOTUS review of long-running PCSK9 patent fight

Amgen seeks SCOTUS review of long-running PCSK9 patent fight
Fraiser Kansteiner FIERCEPHARMA
30 Nov 2021
Share Share
SEC refuses local trial waiver for Novartis’ inclisiran injection

SEC refuses local trial waiver for Novartis’ inclisiran injection
PHARMABIZ
26 Oct 2021
Share Share
Esperion to cute 170 staffers as heart disease pill sputters

Esperion to cute 170 staffers as heart disease pill sputters
V. Singh YAHOOFINANCE
19 Oct 2021
Share Share
Kaiser sues big drugmakers around delayed generics

Kaiser sues big drugmakers around delayed generics
BIZJOURNALS
02 Aug 2021
Share Share
FDA requests removal of warning against using cholesterol-lowering statins

FDA requests removal of warning against using cholesterol-lowering statins
FDA
20 Jul 2021
Share Share
Madrigal Pharma Offers Patients Resmetirom in Phase 3 MAESTRO-NAFLD-1 Study

Madrigal Pharma Offers Patients Resmetirom in Phase 3 MAESTRO-NAFLD-1 Study
GLOBENEWSWIRE
13 Jul 2021
Share Share
Cholesterol & Triglyceride Abnormalities on a Rise, Driving Dyslipidemia Drugs

Cholesterol & Triglyceride Abnormalities on a Rise, Driving Dyslipidemia Drugs
PR NEWSWIRE
16 Mar 2020
Share Share